Preliminary Investigation into the Anti-Tumor Mechanism of Ganoderma lucidum Crude Polysaccharides-tes
Global Biomedical Frontiers · 28.07.2026 · 2 (1)
DOI: 10.67206/ch221f89 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Biomedical Frontiers, online erschienen am 28.07.2026. Verfasst von Jingxia Liu und 1 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
This study aims to explore the potential anti-tumor mechanisms of Ganoderma Lucidum Polysaccharide (GLP). Flow cytometry was employed to investigate the activation effects of GLP on different immune cell subsets. The direct inhibitory effects of GLP on tumor cells were evaluated using CCK assay, MTT assay, and real-time cell monitoring (Cell Index) methods. Additionally, the cytotoxic effects of GLP on cancer-associated fibroblasts (CAF) were examined. A hypothesis was proposed that GLP inhibits tumor development by improving the tumor microenvironment. The results indicate that GLP exerts anti-tumor effects not only by directly killing tumor cells but also by inhibiting the growth of CAFs and primarily promoting CD4+ T cell proliferation.
Zitieren
APA
Liu, J., & Zhao, Y. (2026). Preliminary Investigation into the Anti-Tumor Mechanism of Ganoderma lucidum Crude Polysaccharides-tes. Global Biomedical Frontiers, 2(1). https://doi.org/10.67206/ch221f89
Vancouver
Liu J, Zhao Y. Preliminary Investigation into the Anti-Tumor Mechanism of Ganoderma lucidum Crude Polysaccharides-tes. Global Biomedical Frontiers. 2026;2(1). doi:10.67206/ch221f89
BibTeX
@article{Liu2026,
author = {Liu, Jingxia and Zhao, Yanyan},
title = {Preliminary Investigation into the Anti-Tumor Mechanism of Ganoderma lucidum Crude Polysaccharides-tes},
journal = {Global Biomedical Frontiers},
year = {2026},
volume = {2},
number = {1},
doi = {10.67206/ch221f89}
}
EUVIMED